Astrana Health, Inc. (ASTH) Earnings History
Annual and quarterly earnings data from 2015 to 2025
Loading earnings history...
ASTH EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ASTH Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 9.3% | 2.5% | 0.7% |
| 2024 | 13.3% | 4.4% | 2.1% |
| 2023 | 15.5% | 6.1% | 4.4% |
| 2022 | 17.4% | 9.1% | 3.9% |
| 2021 | 23.0% | 12.7% | 8.9% |
Download Data
Export ASTH earnings history in CSV or JSON format
Free sign-in required to download data
Astrana Health, Inc. (ASTH) Earnings Overview
As of May 8, 2026, Astrana Health, Inc. (ASTH) reported trailing twelve-month net income of $30M, reflecting -48.9% year-over-year growth. The company earned $0.62 per diluted share over the past four quarters, with a net profit margin of 0.7%.
Looking at the long-term picture, ASTH's 5-year EPS compound annual growth rate (CAGR) stands at -14.6%, signaling declining earnings. The company achieved its highest annual net income of $69M in fiscal 2021.
Astrana Health, Inc. maintains positive profitability with a gross margin of 9.3%, operating margin of 2.5%, and net margin of 0.7%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including ALHC ($20M net income, -0.0% margin), CLOV (-$57M net income, -4.4% margin), OSCR (-$39M net income, -3.8% margin), ASTH has outperformed on profitability metrics. Compare ASTH vs ALHC →
ASTH Earnings vs Peers
Earnings metrics vs comparable public companies
ASTH Historical Earnings Data (2015–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $22M | -47.9% | $79M | $0.46 | 0.7% | 2.5% |
| 2024 | $43M | -28.9% | $89M | $0.90 | 2.1% | 4.4% |
| 2023 | $61M | +34.4% | $85M | $1.29 | 4.4% | 6.1% |
| 2022 | $45M | -34.5% | $104M | $0.99 | 3.9% | 9.1% |
| 2021 | $69M | +390.2% | $98M | $1.52 | 8.9% | 12.7% |
| 2020 | -$24M | -268.3% | $6M | $1.01 | -6.4% | 1.6% |
| 2019 | $14M | +30.3% | $32M | $0.39 | 2.5% | 5.8% |
| 2018 | $11M | -58.0% | $92M | $0.29 | 2.1% | 17.7% |
| 2017 | $26M | +376.1% | $38M | $0.90 | 7.2% | 10.5% |
| 2015 | -$9M | - | -$7M | $-1.79 | -21.2% | -14.9% |
See ASTH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ASTH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ASTH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonASTH — Frequently Asked Questions
Quick answers to the most common questions about buying ASTH stock.
Is ASTH growing earnings?
ASTH EPS fell to $0.62, with earnings declining -48.9%. This contrasts with the 5-year CAGR of -14.6%. TTM net income dropped to $30M.
What are ASTH's profit margins?
Astrana Health, Inc. net margin is +0.7%, with operating margin at +2.5%. Below-average margins reflect competitive or cost pressures.
How consistent are ASTH's earnings?
ASTH earnings data spans 2015-2025. The declining earnings trend is -48.9% YoY. Historical data enables comparison across business cycles.